APA (7th ed.) Citation

R, X., P, L., L, W., S, Z., H, L., C, R., . . . Y, T. (2026). Elucidating the pharmacological mechanism of Yangming-Kaixin-Yizhi formula in inhibiting neuronal ferroptosis via Nrf2 in Alzheimer's disease: A study combining network pharmacology, transcriptomics, and experimental validation. Metabolic brain disease, 41(1), . https://doi.org/10.1007/s11011-026-01814-y

Chicago Style (17th ed.) Citation

R, Xiong, et al. "Elucidating the Pharmacological Mechanism of Yangming-Kaixin-Yizhi Formula in Inhibiting Neuronal Ferroptosis via Nrf2 in Alzheimer's Disease: A Study Combining Network Pharmacology, Transcriptomics, and Experimental Validation." Metabolic Brain Disease 41, no. 1 (2026). https://doi.org/10.1007/s11011-026-01814-y.

MLA (9th ed.) Citation

R, Xiong, et al. "Elucidating the Pharmacological Mechanism of Yangming-Kaixin-Yizhi Formula in Inhibiting Neuronal Ferroptosis via Nrf2 in Alzheimer's Disease: A Study Combining Network Pharmacology, Transcriptomics, and Experimental Validation." Metabolic Brain Disease, vol. 41, no. 1, 2026, https://doi.org/10.1007/s11011-026-01814-y.